Dr. Scott Lindhorst

Rodney J. Schlosser, M.D. is the director of rhinology and sinus surgery at the nose and sinus center. After graduating from the U.S. Military Academy at West Point and serving four years of active military duty in the U.S. Army, Dr. Schlosser received his medical degree from the Mayo Clinic. He then completed his ENT residency at the University of Virginia where he trained under the mentorship of Charles W. Gross, M.D. a nationally recognized sinus surgeon and pediatric otolaryngologist. After his residency, Dr. Schlosser completed an additional year of study during a fellowship devoted exclusively to the treatment of advanced sinus disease at the University of Pennsylvania with David W. Kennedy, M.D. one of the premiere sinus surgeons in the world.Dr. Schlosser has written a textbook on the management of sinus problems and more than 200 articles and chapters dealing with sinus and nasal topics. He regularly travels around the world to speak and teach courses on the latest techniques in endoscopic sinus surgery and computerized image-guided surgery. Dr. Schlosser focuses primarily on difficult adult and pediatric sinus cases, nasal obstruction, revision surgeries, sinonasal tumors. Dr. Schlosser is highly rated in 22 conditions, according to our data. His top areas of expertise are Sinusitis, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Cerebrospinal Fluid Leak, Septoplasty, and Endoscopy.

Robert Stuart is a Hematologist and an Oncologist in Charleston, South Carolina. Dr. Stuart is highly rated in 37 conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Dr. Thai Ho has been caring for patients affected by genitourinary cancers for over 10 years. His area of expertise and the focus of his research is in treating kidney and bladder cancers. He also sees patients with kidney, bladder, upper tract urothelial, and prostate cancers, as well as patients affected by hereditary cancer syndromes. Dr. Ho completed the Baylor College of Medicine Physician Scientist Program in 2006, internal medicine residency at Washington University in St. Louis in 2009, and Medical Oncology Fellowship at MD Anderson Cancer Center in 2012.Dr. Ho's research is funded by the National Institutes of Health and Department of Defense to better match cancer patients with targeted therapies by using precision medicine approaches to identify a cancer's unique vulnerabilities. At MUSC Hollings Cancer Center, Dr. Ho is the Director of Precision Medicine and an Associate Professor in the Division of Hematology \& Oncology. Prior to joining MUSC, Dr. Ho was an Associate Professor faculty the Mayo Clinic where he was a member of the Center for Individualized Medicine Epigenomics Group, Genomic Tumor Board, and von Hippel-Lindau Clinic. Dr. Ho is highly rated in 17 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Orchiectomy.